Clinical trials: Heart Failure, Unspecified
Heart Failure
Hospitalization at Home of Elderly Patients With Heart Failure
Aim of the study was to evaluate the efficacy of hospital-at-home treatment compared with inpatient care in selected elderly patients with acute exacerbation of chronic heart failure (CHF).
- Trial name
- NCT00623571
- Testing
- Treatment of elderly patients in a GMW, Treatment of elderly patients in GHHS
- Where
- Italy
- Volunteers
- 101 people
- Sponsor
- Azienda Ospedaliera San Giovanni Battista
Congestive Heart Failure
Safety Trial of OPC-61815 Injection in Patients With Congestive Heart Failure Who Have Difficulty With or Are Incapable of Oral Intake
To confirm the tolerability of intravenous administration of OPC-61815 at 8 or 16 mg once daily for a maximum of 5 days to CHF patients with volume overload despite having received diuretics (injection) other than vasopressin…
- Trial name
- NCT03962101
- Testing
- OPC-61815 injection
- Where
- Japan
- Volunteers
- 45 people
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
Heart Failure
Medtronic Observational Study in the "Real World" of Implantable Electronic Cardiac Devices
The Observational Study in the "Real World" of Implantable Electronic Cardiac Devices will enable the construction of an electronic database with local access to clinical information, which will collect and disseminate…
- Trial name
- OBSERVE (NCT01189630)
- Where
- Brazil
- Volunteers
- 3,500 people
- Sponsor
- Medtronic Comercial Ltda.
Atrial Fibrillation
Catheter Ablation for Atrial Fibrillation in Preserved Ejection Fraction
Atrial fibrillation (AF) displays high prevalence in heart failure with preserved ejection fraction (HF-PEF) and compromises prognosis of affected patients.
- Trial name
- AFFECT (NCT04317911)
- Testing
- Catheter Ablation
- Where
- Germany
- Volunteers
- 102 people
- Sponsor
- University Hospital Heidelberg
Heart Failure
DAPAgliflozin Versus Thiazide Diuretic in Patients With Heart Failure and Diuretic RESISTance
To assess the effect of dapagliflozin compared with metolazone, added to furosemide, on diuresis and decongestion in hospitalised heart failure patients with diuretic resistance, and renal impairment.
- Trial name
- DAPARESIST (NCT04860011)
- Testing
- Dapagliflozin 10 MG Oral Tablet, Metolazone Tablets
- Where
- 2 sites in United Kingdom
- Volunteers
- 61 people
- Sponsor
- NHS Greater Glasgow and Clyde
Heart Failure
Real-world Dapagliflozin Experience in Patients With Heart Failure in United Kingdom.
Heart failure (HF) is a global, public health issue that affects more than 63 million people worldwide; this burden is expected to increase substantially as the population ages.
- Trial name
- EVOLUTION-HF (NCT05188144)
- Where
- 10 sites in United Kingdom
- Volunteers
- 237 people
- Sponsor
- AstraZeneca
Heart Failure
The Heart Failure Readmission Intervention by Variable Early Follow-up (THRIVE) Study
This study is a pragmatic randomized clinical trial to determine the effectiveness of two strategies of early follow-up in adults after hospitalization for heart failure: telephone follow-up with a heart failure care manager vs.
- Trial name
- THRIVE (NCT03524534)
- Testing
- Telephone Call, In-Person Primary Care Clinical Follow-Up Visit
- Volunteers
- 2,091 people
- Sponsor
- Kaiser Permanente
Heart Failure With Reduced Ejection Fraction, Diabetes Mellitus
Efficacy and Safety of Finerenone in Heart Failure With Reduced Ejection Fraction
Finerenone is a new selective nonsteroidal mineral corticoid receptor antagonist (MRA), nowadays it's widely used in type 2 diabetes (T2DM) patients with chronic kidney disease (CKD), the newest trial shows finerenone improve the…
- Conditions
- Heart Failure With Reduced Ejection Fraction, Diabetes Mellitus, Diabetic Nephropathies
- Trial name
- NCT05974566
- Volunteers
- 60 people
- Sponsor
- Chongqing Medical University
Non-Ischemic Congestive Heart Failure
Safety and Efficacy of Adipose Derived Stem Cells for Non-Ischemic Congestive Heart Failure
The intent of this clinical study is to answer the questions: 1. Is the proposed treatment safe 2. Is treatment effective in improving the disease pathology of patients with Heart Disease as assessed by a series of measurements…
- Trial name
- NCT01502501
- Testing
- Harvesting and Implantation of Adipose-Derived Stem Cells (ASCs)
- Where
- Mexico
- Sponsor
- Ageless Regenerative Institute
Ischemic Heart Disease, Bone Marrow Cells
Autologous Bone Marrow Mononuclear Cells in the Combined Treatment of Coronary Heart Disease
The purpose of this study evaluate the effect of the method of administration of autologous bone marrow mononuclear cells for the duration of of functioning aorto-coronary bypass grafts in the surgical treatment of coronary heart…
- Conditions
- Ischemic Heart Disease, Bone Marrow Cells, Coronary Artery Bypass Grafting (CABG), Heart Failure, Diastolic
- Trial name
- TAMIS (NCT02059512)
- Testing
- Group 1, Group 0, Group 2
- Where
- Russia
- Volunteers
- 117 people
- Sponsor
- St. Petersburg State Pavlov Medical University
Heart Failure
Automated MEdical Record Driven Implantable CArdioverter-defibrillator Heart Failure Trial (AMERICA-HF)
Purpose and Objective: Heart failure therapies including beta-blockers, ACE-inhibitors, aldosterone antagonists, implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy (CRT) devices have proven…
- Trial name
- AMERICA-HF (NCT01807130)
- Testing
- Automated HF/EP Referral
- Where
- United States
- Volunteers
- 77 people
- Sponsor
- Duke University
Neoplasms, Heart Failure
Ivabradine to Prevent Anthracycline-induced Cardiotoxicity
Anthracyclines are associated with cardiotoxic effects. Previous studies suggest that enalapril, and or carvedilol, protect against cardiovascular effects of these drugs.
- Conditions
- Neoplasms, Heart Failure, Cardiotoxicity, Chemotherapy Effect
- Trial name
- IPAC (NCT03650205)
- Testing
- Ivabradine
- Where
- Brazil
- Volunteers
- 160 people
- Sponsor
- University of Sao Paulo
Heart Failure With Preserved Ejection Fraction, Pulmonary Hypertension
Exercise Right Ventricular Coupling in HFpEF
The investigators aim to evaluate the feasibility and prognostic value of right ventricular-arterial coupling (RVAC) during exercise in patients with HFpEF-PH using a hybrid technique of real-time CMRderived volume measures and…
- Trial name
- ENDURE (NCT05731466)
- Testing
- CardioMems HF System
- Where
- Belgium
- Volunteers
- 30 people
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
Heart Failure
Acute Response to Left Bundle Branch Area Pacing With SyncAV
This clinical investigation is a prospective, single-arm, post-market, non-randomized, single-center study designed to evaluate the effectiveness of the SyncAV CRT dynamic atrioventricular (AV) delay feature when used with left…
- Trial name
- NCT06436053
- Testing
- LBBAP with SyncAV
- Where
- Italy
- Volunteers
- 50 people
- Sponsor
- Abbott Medical Devices
Heart Failure
Comparison Between Internal and External Chest Impedance Measurement
To compare two methods of chest impedance: the Medtronics Optivol Measurement via CRT pacemakers for patients with heart failure and external non-invasive measurement
- Trial name
- NCT01296282
- Testing
- Medronics CRT Optivol Impedance Measurement, External Thoracic Impedance Measurement
- Where
- Israel
- Volunteers
- 50 people
- Sponsor
- Hillel Yaffe Medical Center
Chronic Heart Failure, CKD Stage 3
Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System
The REFORM-HF study aims to test a new technology, AQUAPASS, designed to assist patients experiencing symptoms of fluid overload due to Heart Failure.
- Trial name
- REFORM-HF (NCT06360380)
- Testing
- AquaPass System
- Where
- 10 sites in United States, Israel
- Volunteers
- 40 people
- Sponsor
- AquaPass Medical Ltd.
CHF - Congestive Heart Failure, COPD
Transitional Care Model Evaluation 2020
The study is a randomized controlled trial to estimate the effects of the transitional care model (TCM) on hospital admissions and patients' experience during the year following the patient's qualifying discharge.
- Conditions
- CHF - Congestive Heart Failure, COPD, Pneumonia
- Trial name
- TCM2020 (NCT04212962)
- Testing
- Transitional care model (TCM), Usual care
- Where
- United States
- Volunteers
- 962 people
- Sponsor
- Mathematica Policy Research, Inc.
Heart Failure, Diabetes
SHAPES: Supporting Multimorbid Older People
The Smart \& Healthy Ageing through People Engaging in Supportive Systems (SHAPES) Innovation Action is a Horizon 2020, EU-wide project looking at how technology can enable the older population to live healthier lives at home.
- Conditions
- Heart Failure, Diabetes, Diabetes Mellitus
- Trial name
- NCT05249062
- Testing
- SHAPES app
- Where
- United Kingdom
- Volunteers
- 4 people
- Sponsor
- Prof Michael Scott
Advanced Heart Failure
Advanced Care Management in Patients With Advanced Heart Failure
The purpose of this study is to explore the trajectory of advanced management care in patients with heart failure over a period of 9 months, then comparing the medical treatment accepted by patients after 2 years later and…
- Trial name
- NCT03526627
- Where
- Taiwan
- Volunteers
- 227 people, healthy volunteers welcome
- Sponsor
- National Taiwan University Hospital
Coronary Artery Disease, Atrial Fibrillation
Reviving Early Diagnosis of Cardiovascular Disease in the Utrecht Health Project
The goal of this randomized trial is to compare the diagnostic yield of a screen-like early diagnosis strategy to usual primary care to detect coronary artery disease (CAD), atrial fibrillation (AF), heart failure (HF), and/or…
- Conditions
- Coronary Artery Disease, Atrial Fibrillation, Heart Failure, Valvular Heart Disease
- Trial name
- RED-LRGP (NCT05775354)
- Testing
- Early diagnosis strategy
- Where
- Netherlands
- Volunteers
- 1,476 people
- Sponsor
- UMC Utrecht
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.